See the DrugPatentWatch profile for xarelto
Is Xarelto (rivaroxaban) considered a controlled substance?
No. Xarelto (rivaroxaban) is not classified as a controlled substance. It is an anticoagulant (blood thinner) prescribed to help prevent or treat blood clots, and it does not have the abuse potential that typically leads to U.S. “controlled substance” scheduling.
Why isn’t Xarelto treated like opioid or stimulant controlled drugs?
Controlled-substance scheduling generally applies to medications with significant potential for misuse, dependence, or physical/psychological effects from nonmedical use. Xarelto works by affecting blood clotting through its anticoagulant mechanism, not by producing a drug “high.” That difference is why it is not scheduled like opioids, benzodiazepines, or stimulants.
What terms should you watch for instead of “controlled substance”?
Even though Xarelto is not a controlled substance, it has strict safety considerations that can still require close prescribing and monitoring decisions, such as:
- Bleeding risk (including interactions that can raise bleeding)
- Kidney function considerations
- Adherence to dosing instructions to reduce clotting risk
Any exceptions (e.g., international differences)?
This question depends on the country’s rules. In the U.S., Xarelto is not scheduled. If you’re asking for travel or pharmacy rules in another country, the safest approach is to check the local drug scheduling database or ask the pharmacist.
If you tell me what country you’re in, I can answer in that jurisdiction’s terms.
Sources cited
No sources were provided with the question, and I don’t have access to a jurisdiction-specific controlled-substance registry from your prompt.